Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/10/2003EP1369116A1 Oxalatoplatin and 5-fluorouracil for combination therapy of cancer
12/10/2003EP1368660A2 Assay
12/10/2003EP1368656A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
12/10/2003EP1368647A2 Proteins, genes and their use for diagnosis and treatment of vascular response
12/10/2003EP1368502A2 Alkynylated single-strand oligonucleotide and uses thereof
12/10/2003EP1368494A2 Method and test system for identifying substances which protect nerve cells
12/10/2003EP1368486A2 Formulations for il-11
12/10/2003EP1368479A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368474A1 Polynucleotide useful for modulating cancer cell proliferation
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368472A2 Molecules for disease detection and treatment
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368468A1 83 human secreted proteins
12/10/2003EP1368461A2 Two splice variants of the human pftaire serine/threonine kinase
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368457A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
12/10/2003EP1368419A2 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368377A2 Modified interferon beta with reduced immunogenicity
12/10/2003EP1368376A2 Pro-apoptotic proteins and dna molecules encoding them
12/10/2003EP1368375A2 Secretory molecules
12/10/2003EP1368372A2 Peptides having affinity for the gp120 viral protein and use thereof
12/10/2003EP1368371A2 Transfection complexes
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368060A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
12/10/2003EP1368056A1 Recombinant gelatin-like proteins for use as plasma expanders
12/10/2003EP1368055A2 Combined use of derivatives of glp-1 analogs and ppar ligands
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368053A2 Compositions and methods for treating gonadotrophin related illnesses
12/10/2003EP1368051A2 Urocortin-iii and uses thereof
12/10/2003EP1368050A2 Virus derived antimicrobial peptides
12/10/2003EP1368049A2 Inhibition of atf2 activity to treat cancer
12/10/2003EP1368039A2 Aminoglycoside treatment for lysosomal storage diseases
12/10/2003EP1368017A2 Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367980A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
12/10/2003EP1148897B1 Methods and compositions for healing and repair of articular cartilage
12/10/2003EP1144420B1 Sulfated phosphatidylinositols, their preparation and use
12/10/2003EP1140025B1 Granules for oral administration, process for producing the same, and tablets produced from the granules
12/10/2003EP1049711B1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0958371B1 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/10/2003EP0932618B1 Peptide analogues containing a 7-membered lactam ring
12/10/2003EP0912611B1 Human monoclonal antibodies to the hepatitis b surface antigen
12/10/2003EP0862452B1 Stabilizing formulation for ngf
12/10/2003EP0833666B1 Cytomodulating conjugates of members of specific binding pairs
12/10/2003EP0825867B1 N,o-carboxymethylchitosan for prevention of surgical adhesions
12/10/2003EP0824589B1 Utrophin gene promoter
12/10/2003EP0824547B1 Anti-fungal peptides
12/10/2003EP0778779B1 Methods of inducing hair growth and coloration
12/10/2003EP0771146B1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
12/10/2003EP0754059B1 Methods and compositions useful for inhibition of angiogenesis
12/10/2003EP0724456B1 Antibodies to cd40
12/10/2003EP0680316B1 Novel parasitic helminth proteins
12/10/2003EP0679191B1 Detection and treatment of mutations in a cd40 ligand gene
12/10/2003EP0674714B1 Recombinant canine gastric lipase and pharmaceutical compositions
12/10/2003EP0671924B1 Digitalis-like compounds
12/10/2003EP0671920B1 An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1461344A Multivalent target binding protein
12/10/2003CN1461342A Glycosylated VEGF-B and method for increasing amount of soluble VEFG-B
12/10/2003CN1461340A Method of isolating bipotent hepatic progenitor cells
12/10/2003CN1461309A Inhibitory PAS domain protein (IPAS) and screening methods related to angiogenesis and tumor progression
12/10/2003CN1461308A Leucine-based motif and clostridial neurotoxins
12/10/2003CN1461221A Treatment of hepatitis C with thymosin and pegylated interferon
12/10/2003CN1461215A A personal condition management system
12/10/2003CN1461211A Microparticles for pulmonary administation
12/10/2003CN1460520A Compound alliin enteric solubility capsule
12/10/2003CN1460519A Application of boningmycin for curing psoriasis and seborrheic dermatitis
12/10/2003CN1130461C Thrombolytic enzyme and its preparing method and application
12/10/2003CN1130374C Synthetic peptide analogs of lung surfactant protein SP-C
12/10/2003CN1130372C 肽衍生物 Peptide derivatives
12/10/2003CN1130347C 2,3-methylene amino acid compounds, their preparing method and pharmaceutical composition containing them
12/10/2003CN1130227C Viral agent associated with mystery swine disease
12/10/2003CN1130224C Low sugar content, stabilized, albumin-free recombinant coagulation factor preparation
12/10/2003CN1130223C Pharmaceutical formulation containing growth hormone, amino acid and non-ionic detergent
12/10/2003CN1130222C Aqueous prolonged release formulation
12/10/2003CN1130221C Use of glial neurotrophic factor (GDNF) for treatment of hearing disorders
12/10/2003CN1130196C Preparation and method of stabilizing biological matericals by non-freezing drying method
12/10/2003CA2389911A1 Broad spectruma antagonists and vaccines directed against pyrogenic exotoxins
12/09/2003US6660906 Tpl2 transgenic knockout mice
12/09/2003US6660848 Signal Transducer and Activator of Transcription (STAT) proteins are a new class of intracellular transcription factors
12/09/2003US6660846 DNA fragment that encodes an amino acid synaptic vesicle transporter protein that is capable of effecting the passage of GABA into a synaptic vesicle
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/09/2003US6660842 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
12/09/2003US6660840 Ability to stimulate a Th1 response in peripheral blood mononuclear cells; contain a biologically active portion of a Leishmania braziliensis
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660838 Compounds and methods for therapy and diagnosis of lung cancer
12/09/2003US6660835 Lead substances and their use as therapeutics
12/09/2003US6660833 A dimer of a synthetic lung surfactant protein B
12/09/2003US6660831 Administering to an individual having the disorder an effective amount of secretin to improve a symptom of the disorder
12/09/2003US6660830 Peptides with antiproliferative properties
12/09/2003US6660748 1-azabicyclo(2.2.1)heptane or quinuclidine derivatives; treating or preventing neuronal damage associated with neurological diseases
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660741 Coupling an O-protected methoxypyrrolidine or derivatives with N-protected amino acid 2,5-dioxo-pyrrolidinyl ester to form intermediate, deportecting with trifluoroacetic acid to form pyrrolidine-1-carbonyl-2-methylamine or derivatives
1 ... 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 ... 3163